TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cardlytics ( (CDLX) ) just unveiled an announcement.
On July 7, 2025, Cardlytics, Inc. announced the extension of its Master Agreement with JPMorgan Chase Bank until November 18, 2028, through a Fourth Amendment. This amendment includes changes to Supplier Billings Share, Incentive Bonus, and Quality Credits, with a notable reduction in Supplier Billings Share starting January 1, 2026, although it remains higher than the level before the Third Amendment.
The most recent analyst rating on (CDLX) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Cardlytics stock, see the CDLX Stock Forecast page.
Spark’s Take on CDLX Stock
According to Spark, TipRanks’ AI Analyst, CDLX is a Neutral.
Cardlytics faces significant financial and valuation challenges, as reflected in its negative P/E ratio and high leverage. Technical indicators suggest some stability, but the stock remains under bearish pressure. Despite strategic expansions and increased user engagement, the overall financial health and profitability issues weigh heavily on its attractiveness.
To see Spark’s full report on CDLX stock, click here.
More about Cardlytics
Cardlytics, Inc. operates in the financial technology industry, providing digital advertising services through a platform that leverages purchase data to help marketers reach targeted audiences. The company partners with financial institutions to offer personalized marketing solutions.
Average Trading Volume: 959,206
Technical Sentiment Signal: Sell
Current Market Cap: $95.03M
Learn more about CDLX stock on TipRanks’ Stock Analysis page.